Evidence map›Paper›PMID 38391417›Full record

ArticleGels (Basel, Switzerland)2024

In Vitro Release of Glycyrrhiza Glabra Extract by a Gel-Based Microneedle Patch for Psoriasis Treatment.

Ayeh Khorshidian, Niloufar Sharifi, Fatemeh Choupani Kheirabadi, Farnoushsadat Rezaei, Seyed Alireza Sheikholeslami, Ayda Ariyannejad, Javad Esmaeili, Hojat Basati, Aboulfazl Barati

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gels (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Programmable Paracrine-Mimetic Microneedle System for Temporal Regulation of Cardiac Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Swellable Microneedles in Drug Delivery and Diagnostics.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ayeh KhorshidianDepartment of Biomedical Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.
Niloufar SharifiDepartment of Tissue Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.
Fatemeh Choupani KheirabadiDepartment of Tissue Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.
Farnoushsadat RezaeiDepartment of Chemical and Biomedical Engineering, University of Missouri, Columbia, MO 65211, USA.
Seyed Alireza SheikholeslamiDepartment of Tissue Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.
Ayda AriyannejadDepartment of Tissue Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.
Javad EsmaeiliDepartment of Tissue Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.ORCID 0000-0003-2853-9916
Hojat BasatiDepartment of Tissue Engineering, TISSUEHUB Co., Tehran 1956854977, Iran.
Aboulfazl BaratiCenter for Materials and Manufacturing Sciences, Department of Chemistry and Physics, Troy University, Troy, AL 36082, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microneedle patches are attractive drug delivery systems that give hope for treating skin disorders. In this study, to first fabricate a chitosan-based low-cost microneedle patch (MNP) using a CO

Indexed as

burst releasedrug deliverymicroneedle patchpsoriasisskin disorder

Identifiers

PMID38391417
PMCPMC10887857

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.